179 related articles for article (PubMed ID: 32568366)
21. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease.
Wang F; Gordon BA; Ryman DC; Ma S; Xiong C; Hassenstab J; Goate A; Fagan AM; Cairns NJ; Marcus DS; McDade E; Ringman JM; Graff-Radford NR; Ghetti B; Farlow MR; Sperling R; Salloway S; Schofield PR; Masters CL; Martins RN; Rossor MN; Jucker M; Danek A; Förster S; Lane CA; Morris JC; Benzinger TL; Bateman RJ;
Neurology; 2015 Sep; 85(9):790-8. PubMed ID: 26245925
[TBL] [Abstract][Full Text] [Related]
22. Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease.
Ali M; Archer DB; Gorijala P; Western D; Timsina J; Fernández MV; Wang TC; Satizabal CL; Yang Q; Beiser AS; Wang R; Chen G; Gordon B; Benzinger TLS; Xiong C; Morris JC; Bateman RJ; Karch CM; McDade E; Goate A; Seshadri S; Mayeux RP; Sperling RA; Buckley RF; Johnson KA; Won HH; Jung SH; Kim HR; Seo SW; Kim HJ; Mormino E; Laws SM; Fan KH; Kamboh MI; Vemuri P; Ramanan VK; Yang HS; Wenzel A; Rajula HSR; Mishra A; Dufouil C; Debette S; Lopez OL; DeKosky ST; Tao F; Nagle MW; ; ; ; ; ; Hohman TJ; Sung YJ; Dumitrescu L; Cruchaga C
Acta Neuropathol Commun; 2023 Apr; 11(1):68. PubMed ID: 37101235
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
24. Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.
Ramanan VK; Heckman MG; Przybelski SA; Lesnick TG; Lowe VJ; Graff-Radford J; Mielke M; Jack CR; Knopman DS; Petersen RC; Ross OA; Vemuri P;
J Alzheimers Dis; 2022; 88(4):1615-1625. PubMed ID: 35811524
[TBL] [Abstract][Full Text] [Related]
25. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.
Yassine HN; Feng Q; Azizkhanian I; Rawat V; Castor K; Fonteh AN; Harrington MG; Zheng L; Reed BR; DeCarli C; Jagust WJ; Chui HC
JAMA Neurol; 2016 Oct; 73(10):1208-1216. PubMed ID: 27532692
[TBL] [Abstract][Full Text] [Related]
26. The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
Rafii MS; Sperling RA; Donohue MC; Zhou J; Roberts C; Irizarry MC; Dhadda S; Sethuraman G; Kramer LD; Swanson CJ; Li D; Krause S; Rissman RA; Walter S; Raman R; Johnson KA; Aisen PS
Alzheimers Dement; 2023 Apr; 19(4):1227-1233. PubMed ID: 35971310
[TBL] [Abstract][Full Text] [Related]
27. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
[TBL] [Abstract][Full Text] [Related]
28. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.
Villeneuve S; Vogel JW; Gonneaud J; Pichet Binette A; Rosa-Neto P; Gauthier S; Bateman RJ; Fagan AM; Morris JC; Benzinger TLS; Johnson SC; Breitner JCS; Poirier J;
JAMA Neurol; 2018 May; 75(5):608-619. PubMed ID: 29482212
[TBL] [Abstract][Full Text] [Related]
29. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
[TBL] [Abstract][Full Text] [Related]
30. Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
Ozlen H; Pichet Binette A; Köbe T; Meyer PF; Gonneaud J; St-Onge F; Provost K; Soucy JP; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
JAMA Neurol; 2022 Oct; 79(10):1025-1035. PubMed ID: 35994280
[TBL] [Abstract][Full Text] [Related]
31. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
32. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
[TBL] [Abstract][Full Text] [Related]
33. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
34. Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment.
Hu Y; Kirmess KM; Meyer MR; Rabinovici GD; Gatsonis C; Siegel BA; Whitmer RA; Apgar C; Hanna L; Kanekiyo M; Kaplow J; Koyama A; Verbel D; Holubasch MS; Knapik SS; Connor J; Contois JH; Jackson EN; Harpstrite SE; Bateman RJ; Holtzman DM; Verghese PB; Fogelman I; Braunstein JB; Yarasheski KE; West T
JAMA Netw Open; 2022 Apr; 5(4):e228392. PubMed ID: 35446396
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
[TBL] [Abstract][Full Text] [Related]
36. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.
Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA
JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159
[TBL] [Abstract][Full Text] [Related]
37. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes.
Jack CR; Wiste HJ; Botha H; Weigand SD; Therneau TM; Knopman DS; Graff-Radford J; Jones DT; Ferman TJ; Boeve BF; Kantarci K; Lowe VJ; Vemuri P; Mielke MM; Fields JA; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Petersen RC
Brain; 2019 Oct; 142(10):3230-3242. PubMed ID: 31501889
[TBL] [Abstract][Full Text] [Related]
38. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
39. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.
Kunkle BW; Schmidt M; Klein HU; Naj AC; Hamilton-Nelson KL; Larson EB; Evans DA; De Jager PL; Crane PK; Buxbaum JD; Ertekin-Taner N; Barnes LL; Fallin MD; Manly JJ; Go RCP; Obisesan TO; Kamboh MI; Bennett DA; Hall KS; Goate AM; Foroud TM; Martin ER; Wang LS; Byrd GS; Farrer LA; Haines JL; Schellenberg GD; Mayeux R; Pericak-Vance MA; Reitz C; ; Graff-Radford NR; Martinez I; Ayodele T; Logue MW; Cantwell LB; Jean-Francois M; Kuzma AB; Adams LD; Vance JM; Cuccaro ML; Chung J; Mez J; Lunetta KL; Jun GR; Lopez OL; Hendrie HC; Reiman EM; Kowall NW; Leverenz JB; Small SA; Levey AI; Golde TE; Saykin AJ; Starks TD; Albert MS; Hyman BT; Petersen RC; Sano M; Wisniewski T; Vassar R; Kaye JA; Henderson VW; DeCarli C; LaFerla FM; Brewer JB; Miller BL; Swerdlow RH; Van Eldik LJ; Paulson HL; Trojanowski JQ; Chui HC; Rosenberg RN; Craft S; Grabowski TJ; Asthana S; Morris JC; Strittmatter SM; Kukull WA
JAMA Neurol; 2021 Jan; 78(1):102-113. PubMed ID: 33074286
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.
Vos SJ; Xiong C; Visser PJ; Jasielec MS; Hassenstab J; Grant EA; Cairns NJ; Morris JC; Holtzman DM; Fagan AM
Lancet Neurol; 2013 Oct; 12(10):957-65. PubMed ID: 24012374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
